VT
EW icon

Vise Technologies’s Edwards Lifesciences EW Stock Holding History

Vise Technologies’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$606K Hold
7,113
– – 0.01% 780
2025
Q4 		$606K Buy
7,113
+417
+6% +$34.2K 0.01% 785
2025
Q3 		$521K Sell
6,696
-10,759
-62% -$841K 0.02% 654
2025
Q2 		$1.37M Buy
+17,455
New +$1.3M 0.06% 355
2024
Q4 		$386K Buy
5,209
+1,702
+49% +$119K 0.03% 508
2024
Q3 		$231K Sell
3,507
-3,138
-47% -$228K 0.03% 532
2024
Q2 		$614K Buy
6,645
+2,104
+46% +$186K 0.11% 194
2024
Q1 		$434K Buy
+4,541
New +$381K 0.09% 225

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vise Technologies's EW Position: Q1 2026 in Review

Vise Technologies held its Edwards Lifesciences (EW) position steady in Q1 2026 at 7,113 shares worth $606K. The position accounts for 0.01% of the portfolio, ranked #780.

Vise Technologies first reported a position in EW in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.37M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Vise Technologies held 7,113 shares of Edwards Lifesciences worth $606K as of Q1 2026.
  • Vise Technologies left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.01% of Vise Technologies's portfolio in Q1 2026, its #780 holding.
  • Vise Technologies first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 8 quarters since.
  • Vise Technologies's Edwards Lifesciences position peaked at $1.37M in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.